Publicaciones en las que colabora con Pablo Aguiar Fernández (9)

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. Periodontitis and vascular inflammatory biomarkers: an experimental in vivo study in rats

    Odontology, Vol. 108, Núm. 2, pp. 202-212

2019

  1. Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptides

    Archives of Oral Biology, Vol. 99, pp. 120-125

2017

  1. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36

    Movement Disorders, Vol. 32, Núm. 2, pp. 264-273

2014

  1. Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.

    Clinical nuclear medicine, Vol. 39, Núm. 4, pp. 399-401

2012

  1. Familial hemiplegic migraine with prolonged global aura: Follow-up findings of subtraction ictal SPECT co-registered to MRI (SISCOM)

    Cephalalgia, Vol. 32, Núm. 13, pp. 1013-1014